LabCorp 2014 Annual Report Download - page 85

Download and view the complete annual report

Please find page 85 of the 2014 LabCorp annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 128

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • 81
  • 82
  • 83
  • 84
  • 85
  • 86
  • 87
  • 88
  • 89
  • 90
  • 91
  • 92
  • 93
  • 94
  • 95
  • 96
  • 97
  • 98
  • 99
  • 100
  • 101
  • 102
  • 103
  • 104
  • 105
  • 106
  • 107
  • 108
  • 109
  • 110
  • 111
  • 112
  • 113
  • 114
  • 115
  • 116
  • 117
  • 118
  • 119
  • 120
  • 121
  • 122
  • 123
  • 124
  • 125
  • 126
  • 127
  • 128

F-6
LABORATORY CORPORATION OF AMERICA HOLDINGS AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS’ EQUITY
(In Millions)
Common
Stock
Additional
Paid-in
Capital Retained
Earnings Treasury
Stock
Accumulated
Other
Comprehensive
Income (Loss)
Total
Shareholders’
Equity
BALANCE AT DECEMBER 31, 2011 $ 11.7 $ — $ 3,387.2 $ (940.9) $ 45.5 $ 2,503.5
Net earnings attributable to Laboratory Corporation of America
Holdings — — 583.1 — — 583.1
Other comprehensive earnings, net of tax ———— 23.9 23.9
Issuance of common stock under employee stock plans 0.1 85.1 85.2
Surrender of restricted stock and performance share awards (10.9) (10.9)
Conversion of zero-coupon convertible debt ———— —
Stock compensation 40.7 40.7
Income tax benefit from stock options exercised 8.4 8.4
Purchase of common stock (0.5) (134.2) (381.8) (516.5)
BALANCE AT DECEMBER 31, 2012 $ 11.3 $ — $ 3,588.5 $ (951.8) $ 69.4 $ 2,717.4
Net earnings attributable to Laboratory Corporation of America
Holdings — — 573.8 — — 573.8
Other comprehensive earnings, net of tax ———— (3.2) (3.2)
Issuance of common stock under employee stock plans 0.2 173.8 174.0
Surrender of restricted stock and performance share awards (7.1) (7.1)
Conversion of zero-coupon convertible debt 4.1 4.1
Stock compensation 37.3 37.3
Income tax benefit from stock options exercised 10.6 10.6
Purchase of common stock (1.0) (225.8) (788.8) (1,015.6)
BALANCE AT DECEMBER 31, 2013 $ 10.5 $ — $ 3,373.5 $ (958.9) $ 66.2 $ 2,491.3
Net earnings attributable to Laboratory Corporation of America
Holdings — — 511.2 — — 511.2
Other comprehensive earnings, net of tax ————(76.7) (76.7)
Issuance of common stock under employee stock plans 0.2 114.6 114.8
Surrender of restricted stock and performance share awards (6.6) (6.6)
Conversion of zero-coupon convertible debt 3.9 3.9
Stock compensation 45.7 45.7
Income tax benefit from stock options exercised 5.9 5.9
Purchase of common stock (0.3) (170.1) (98.6) (269.0)
BALANCE AT DECEMBER 31, 2014 $ 10.4 $ $ 3,786.1 $ (965.5) $ (10.5) $ 2,820.5
The accompanying notes are an integral part of these consolidated financial statements.